首页> 外国专利> EFFECT OF ORALLY ADMINISTERED DIPTERINYL CALCIUM PENTAHYDRATE (DCP) ON ORAL GLUCOSE TOLERANCE IN DIO MICE

EFFECT OF ORALLY ADMINISTERED DIPTERINYL CALCIUM PENTAHYDRATE (DCP) ON ORAL GLUCOSE TOLERANCE IN DIO MICE

机译:口服戊二酸二钙钙盐(DCP)对DIO小鼠口服糖耐量的影响

摘要

Provided herein are methods of treating diabetes comprising administering to a subject a therapeutically effective amount of dipterinyl calcium pentahydrate (DCP). Dipterinyl calcium pentahydrate (DCP) is a molecular entity whose structure is based upon the endogenous substance pterin, has effects on glucose tolerance and other measures in vivo were determined in mice fed a high-fat diet to induce obesity and insulin resistance. DCP was found to significantly improve oral glucose tolerance (OGTT) in female DIO mice,C57BL/67.
机译:本文提供了治疗糖尿病的方法,该方法包括向受试者施用治疗有效量的五水合二蝶烷基钙(DCP)。二水蝶呤五水合钙(DCP)是一种分子实体,其结构基于内源性蝶呤,对葡萄糖耐量有影响,并且在高脂饮食喂养的小鼠中确定了体内其他措施以诱导肥胖和胰岛素抵抗。发现DCP可显着改善雌性DIO小鼠C57BL / 67的口服葡萄糖耐量(OGTT)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号